Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.

Autor: Tsuchihashi K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan., Ito M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan., Okumura Y; Department of Gastrointestinal and Medical Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan., Nio K; Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan., Ozaki Y; Department of Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Nishio H; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan., Ichihara E; Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan., Miura Y; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan., Endo M; Department of Orthopaedic Surgery, Kyushu University, Fukuoka, Japan., Yano S; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Maruyama D; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Yoshinami T; Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan., Susumu N; Department of Obstetrics and Gynecology, International University of Health and Welfare Narita Hospital, Chiba, Japan., Takekuma M; Department of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan., Motohashi T; Department of Obstetrics and Gynecology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Ochi N; Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan., Kubo T; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan., Uchino K; Department of Medical Oncology, NTT Medical Center Tokyo, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kamiyama Y; Department of Clinical Oncology/Hematology, The Jikei University School of Medicine, Tokyo, Japan., Nakao S; Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan., Tamura S; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan., Nishimoto H; Department of Nursing, Okayama University Hospital, Okayama, Japan., Kato Y; Department of Drug Information, Faculty of Pharmaceutical Sciences, Shonan University of Medical Sciences, Kanagawa, Japan., Sato A; Department of Medical Oncology, Hirosaki University Graduate School of Medicine, Aomori, Japan., Takano T; Department of Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. baba.eishi.889@m.kyushu-u.ac.jp.

Publikováno v: International journal of clinical oncology [Int J Clin Oncol] 2024 Jun; Vol. 29 (6), pp. 700-705. Date of Electronic Publication: 2024 May 02.

Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study.

Autor: Tomomatsu T; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Shimizu H; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Yokokawa T; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Fukada I; Breast Oncology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research., Kawakami K; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Kobayashi K; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Aoyama T; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Suzuki W; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Sugisaki T; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Hashimoto K; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Asano M; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Mori Y; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research., Hara F; Breast Oncology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research., Takano T; Breast Oncology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research., Ohno S; Breast Oncology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research., Yamaguchi M; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research.

Publikováno v: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan [Yakugaku Zasshi] 2024; Vol. 144 (9), pp. 897-904.

Novel biomarkers to identify complicated course of febrile neutropenia in hematological patients receiving intensive chemotherapy.

Autor: Jantunen E; Institute of Clinical Medicine/Internal Medicine, University of Eastern Finland, Kuopio, Finland.; Department of Medicine, Kuopio University Hospital, Wellbeing Services County of North Savo, Kuopio, Finland., Hämäläinen S; Department of Medicine, Kuopio University Hospital, Wellbeing Services County of North Savo, Kuopio, Finland., Pulkki K; Diagnostic Center, Helsinki University Hospital and Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Institute of Clinical Medicine/Clinical Chemistry, University of Eastern Finland, Kuopio, Finland., Juutilainen A; Institute of Clinical Medicine/Internal Medicine, University of Eastern Finland, Kuopio, Finland.

Publikováno v: European journal of haematology [Eur J Haematol] 2024 Oct; Vol. 113 (4), pp. 392-399. Date of Electronic Publication: 2024 Jul 03.

Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting.

Autor: Winget MD; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: mdw.winget@gmail.com., Gatwood K; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee., Jayani R; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Biltibo E; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Jallouk A; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Jerkins J; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Dholaria B; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Kim TK; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Savani B; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Kassim A; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., McNeer E; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Choi L; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Orton L; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Oct; Vol. 30 (10), pp. 1031.e1-1031.e9. Date of Electronic Publication: 2024 Jul 27.

A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia.

Autor: Chaftari AM; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Dagher H; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Hachem R; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Jiang Y; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Lamie P; Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wilson Dib R; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., John T; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Haddad A; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Philip A; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Alii S; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Mulanovich P; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chaftari P; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Raad I; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Oct 01; Vol. 79 (10), pp. 2543-2553.